title: The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: An Invitation to Review and Comment.
authors.affiliation: University of California, San Francisco.
authors.forename: Kirsten
authors.initials: K
authors.lastname: Bibbins-Domingo
authors.affiliation: Kaiser Permanente Washington Health Research Institute, Seattle, Washington.
authors.forename: David C
authors.initials: DC
authors.lastname: Grossman
authors.affiliation: University of Iowa, Iowa City.
authors.forename: Susan J
authors.initials: SJ
authors.lastname: Curry
mesh_terms: D026683:Advisory Committees; D000367:Age Factors; D000368:Aged; D044383:Black People; D003657:Decision Making; D007172:Erectile Dysfunction / Q000209:etiology; D005189:False Positive Reactions; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D000069342:Medical Overuse; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000517:prevention & control; D057240:Patient Preference; D017410:Practice Guidelines as Topic / Q000592:standards*; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D018570:Risk Assessment; D014481:United States; D014549:Urinary Incontinence / Q000209:etiology; D057832:Watchful Waiting; D001741:Black or African American
chemical_list: D017430:Prostate-Specific Antigen